Top 5 Takeaways FDA Approvals and ACIP Recommendations: The FDA issued Emergency Use Authorizations for the Moderna and Pfizer-BioNTech COVID-19 vaccines for children aged 6 months–5 years and 6 months–4
Tag: 2022
Top 5 Takeaways Anemia prevalence increased among pregnant WIC participants. From 2008 to 2018, there was a 13% increase in anemia prevalence among pregnant women enrolled in WIC, from 10.1%
Top 5 Takeaways The highest motor vehicle crash death rate among high-income countries: In 2019, the United States had the highest population-based motor vehicle crash death rate (11.1 per 100,000
Top 5 Takeaways Widespread Provider Availability: As of April 25, 2022, 87.5% of U.S. counties had at least one active COVID-19 vaccine provider for children aged 5–11, primarily pharmacies and
Top 5 Takeaways Higher social vulnerability linked to increased firearm injury ED visits: Counties with higher overall social vulnerability experienced higher rates of emergency department (ED) visits for firearm injuries.
Top 5 Takeaways Immunocompromised patients represented a significant portion of COVID-19 hospitalizations. Accounting for 12.2% of adult COVID-19 hospitalizations across 10 states, immunocompromised patients had increased odds of ICU admission
Top 5 Takeaways Identification of the Outbreak: On January 14, 2022, two inmates at a Nebraska correctional facility were diagnosed with Salmonella Enteritidis, prompting an investigation that linked the outbreak
Top 5 Takeaways Significant Testing Capacity and Results: The Laboratory Response Network (LRN) tested 2,009 specimens for monkeypox, identifying 730 (36.3%) positive cases from 395 patients, with 159 confirmed by
Top 5 Takeaways Case Counts Fluctuated During the Pandemic: Coccidioidomycosis and histoplasmosis case counts dropped in 2020 compared to 2019, but saw an increase in 2021. A notable high blastomycosis
Top 5 Takeaways Reduced Reactions Post-Booster: Immunocompromised individuals aged ≥12 years reported fewer local and systemic reactions after the fourth dose (mRNA booster) compared to after the third dose of